drugset / Trial / NCT07160738
A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to see and learn the effect of multiple doses of a strong CYP3A4 inhibitor and a potent UGT2B7 inhibitor on the PK of PF-07220060.
Timeline
- Start
- 2025-09-22
- Primary completion
- 2025-11-24
- Completion
- 2025-12-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atirmociclib | Small molecule | — | Oral |
| Subject | Itraconazole | Small molecule | — | Oral |
| Subject | Probenecid | Small molecule | — | — |
Indications
No indication recorded.